Epigral Ltd Share Price ₹1,115 | P/E 15.8

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Epigral Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	562	455	478	472	525	651	626	645	628	607	587	597	736
Expenses +	407	360	370	349	369	475	448	463	454	443	455	494	568
Operating Profit	155	95	108	123	155	176	178	183	173	163	132	103	169
OPM %	28%	21%	23%	26%	30%	27%	28%	28%	28%	27%	23%	17%	23%
Other Income +	5	2	1	2	2	2	6	4	3	8	2	6	-1
Interest	19	18	21	20	14	14	27	-0	12	23	22	11	16
Depreciation	30	31	32	31	30	33	32	33	34	42	42	43	42
Profit before tax	110	48	56	74	113	131	124	154	131	107	70	55	111
Tax %	30%	33%	32%	34%	32%	34%	35%	33%	34%	-50%	26%	28%	26%
Net Profit +	77	32	38	49	77	86	81	104	87	160	52	39	82
EPS in Rs	18.48	7.62	9.18	11.87	18.45	20.70	19.38	24.00	20.08	37.18	11.94	9.07	18.99

Financials of Epigral Ltd

Annual income statement trend

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	394	392	598	710	611	829	1,551	2,188	1,929	2,550	2,527
Expenses +	245	248	346	405	416	567	1,041	1,499	1,448	1,839	1,960
Operating Profit	149	144	252	306	194	261	510	689	481	711	567
OPM %	38%	37%	42%	43%	32%	32%	33%	31%	25%	28%	22%
Other Income +	2	1	8	16	2	2	4	8	6	15	15
Interest	19	14	9	25	11	29	44	66	73	53	72
Depreciation	44	55	55	54	44	74	86	109	124	133	168
Profit before tax	88	75	195	242	141	161	383	523	291	540	342
Tax %	23%	11%	20%	25%	21%	37%	34%	32%	33%	34%	3%
Net Profit +	67	67	155	183	112	101	253	353	196	357	333
EPS in Rs	9.49	9.40	21.97	44.38	27.19	24.48	60.84	85.04	47.12	82.68	77.19
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	6%	11%	7%	6%

Financials of Epigral Ltd

Capital structure and asset base

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	71	71	71	41	42	42	42	42	42	43	43
Reserves	224	291	447	241	331	432	684	1,028	1,213	1,860	2,178
Borrowings +	190	123	74	601	737	753	993	879	964	593	572
Other Liabilities +	55	42	79	162	164	223	405	484	576	655	712
Total Liabilities	540	527	671	1,044	1,273	1,449	2,124	2,432	2,794	3,151	3,505
Fixed Assets +	364	398	347	295	440	1,102	1,068	1,804	1,767	2,238	2,117
CWIP	69	3	79	468	691	126	589	158	483	64	451
Investments	0	29	71	0	0	0	0	21	21	97	23
Other Assets +	106	98	173	281	142	221	467	449	524	752	915
Total Assets	540	527	671	1,044	1,273	1,449	2,124	2,432	2,794	3,151	3,505

Financials of Epigral Ltd

Operating, investing and financing cash movement

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	165	229	284	626	398	441	436
Cash from Investing Activity +	-363	-197	-455	-437	-401	-262	-355
Cash from Financing Activity +	69	-32	195	-200	-8	-164	-94
Net Cash Flow	-129	1	24	-11	-11	15	-14
Free Cash Flow	-205	32	-172	210	-1	254	50
CFO/OP	99%	99%	68%	106%	93%	78%	90%

Financials of Epigral Ltd

Working capital efficiency and return ratios

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	43	41	47	40	46	52	60	28	34	33	60
Inventory Days	75	59	45	58	64	51	74	69	90	105	89
Days Payable	31	37	51	52	62	69	42	36	63	50	66
Cash Conversion Cycle	86	63	42	46	48	34	92	61	61	88	83
Working Capital Days	43	40	19	-27	-76	-92	-26	-41	-54	26	16
ROCE %		18%	37%	36%	15%	16%	29%	32%	17%	25%	15%